Сибирский онкологический журнал (Sep 2019)

ANALYSIS OF INFECTIOUS COMPLICATIONS IN CANCER PATIENTS DURING 2014-2016

  • V. V. Aginova,
  • N. V. Dmitrieva,
  • I. N. Petukhova,
  • Z. V. Grigorievskaya,
  • N. S. Bagirova,
  • I. V. Tereshchenko,
  • S. A. Dyakova,
  • T. A. Kalinchuk,
  • A. I. Dmitrieva,
  • V. D. Vinnikova

DOI
https://doi.org/10.21294/1814-4861-2019-18-4-43-49
Journal volume & issue
Vol. 18, no. 4
pp. 43 – 49

Abstract

Read online

The purpose of the study was to analyze infectious complications caused by multi-drug-resistant organisms depending on anticancer therapy.Material and Methods. A total of 229 cancer patients with infectious complications of cancer therapy were included into the study.Results. Lung cancer was the most predominant cancer (26.6 %) followed by gastric cancer (25.3 %) and esophageal cancer (14.4 %). Infectious complications occurring after surgery were observed in 83.4 % of the patients. Infectious complications caused by Acinetobacter baumannii were the most common (40.6 %), followed by Klebsiella pneumoniae (28.5 %), Pseudomonas aeruginosa (19.5 %), Staphylococcus spp. (9.4 %), and Enterococcus spp. (1.8 %).Conclusion. Infectious complications occurred more frequently in postoperative cancer patients (p<0.02), and the ESKAPE group pathogens were the leading cause of these infections.

Keywords